CorMedix Inc. (CRMD) has gained 3.90% Thursday In Premarket Trading

CorMedix Inc. (CRMD) has gained Thursday morning, with the stock gaining 3.90% in pre-market trading to 3.46. CRMD's short-term technical score of 87 indicates that the stock has traded more bullishly over the last month than 87% of stocks on the market. In the Biotechnology industry, which ranks 119 out of 146 industries, CorMedix Inc. ranks higher than 92% of stocks. CorMedix Inc. has risen 0.60% over the past month, closing at $3.23 on October 19. During this period of time, the stock fell as low as $3.00 and as high as $3.62. CRMD has an average analyst recommendation of Strong Buy. The company has an average price target of $13.75.

CRMD has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on CRMD!

See Full CRMD Report

CorMedix Inc. has a Long-Term Technical rank of 23. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 77% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, CRMD ranks better than 132% of stocks.

Important Dates for Investors in CRMD:

-CorMedix Inc. is set to release earnings on 2024-02-12. Over the last 12 months, the company has reported EPS of $-0.76. -We do not have a set dividend date for CorMedix Inc. at this time. Click Here To Get The Full Report on CorMedix Inc. (CRMD)